Loading asset research
COMPASS Pathways Plc American Depository Shares
CMPSNasdaq · USD · StocksQuote as of · Exchange session not verified$14.36
+0.98%
Today
CMPS
Loading 1D prices…
Market cap
$2B
Volume
2M
52w high
$15.8752w low
$4.82Company profile
COMPASS Pathways Plc American Depository Shares
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
London, United Kingdom, United States
Employees
156
Fiscal year end
1231
CIK
1816590
Session & valuation
Open$14.13
Previous close$14.22
Day high$14.65
Day low$14.13
30-day avg. volume2.7M
Outstanding shares138.5M
Diluted EPS-$3.08
Latest annual period
P/E (trailing)-4.66
P/E (forward)-10.01
Price / book23.03
Beta2.55
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AGIOAgios Pharmaceuticals Inc. Common Stock | $2B | $54M | -764.42% | -$7.12 | -0.18% | Buy |
| GENBGenerate Biomedicines Inc. Common Stock | $2B | $31.9M | -636.99% | -$2.18 | +2.21% | Buy |
| ZBIOZenas BioPharma Inc. Common Stock | $2B | $10M | -3777.37% | -$8.44 | +0.14% | Buy |
| BHVNBiohaven Ltd. Common Shares | $1.9B | $0.00 | — | -$6.86 | -0.66% | Buy |
| URGNUroGen Pharma Ltd. Ordinary Shares | $2.1B | $109.8M | -139.81% | -$3.19 | +0.19% | Buy |